Australija - anglų - Department of Health (Therapeutic Goods Administration)

link medical products pty ltd t/a link pharmaceuticals - coal tar,precipitated sulfur,salicylic acid -

Australija - anglų - Department of Health (Therapeutic Goods Administration)

link medical products pty ltd t/a link pharmaceuticals - hydroxycarbamide (hydroxyurea), quantity: 500 mg - capsule, hard - excipient ingredients: indigo carmine; dibasic sodium phosphate heptahydrate; magnesium stearate; titanium dioxide; citric acid; lactose monohydrate; iron oxide yellow; gelatin; erythrosine; propylene glycol; butan-1-ol; isopropyl alcohol; purified water; strong ammonia solution; ethanol absolute; iron oxide black; ethanol; shellac; sulfuric acid - significant tumour response to hydrea has been demonstrated in, chronic myelocytic leukaemia (pretreatment phase and palliative care) and recurrent, metastatic, or inoperable carcinoma of the ovary.

Australija - anglų - Department of Health (Therapeutic Goods Administration)

neon healthcare pty limited - phenelzine sulfate, quantity: 25.83 mg (equivalent: phenelzine, qty 15 mg) - tablet, film coated - excipient ingredients: povidone; magnesium stearate; maize starch; mannitol; titanium dioxide; hypromellose; hyprolose; sunset yellow fcf; purified talc; erythrosine; stearic acid; polyvinyl acetate phthalate - for the treatment of major depression. phenelzine sulfate should rarely be the first antidepressant drug used. rather it is more suitable for use with patients who have failed to respond to the drugs more commonly used for these conditions.

Australija - anglų - Department of Health (Therapeutic Goods Administration)

link medical products pty ltd t/a link pharmaceuticals - acetylcysteine -

Singapūras - anglų - HSA (Health Sciences Authority)

link healthcare singapore pte ltd - methylnaltrexone bromide - injection, solution - 12mg/0.6ml - methylnaltrexone bromide 12mg/0.6ml

Australija - anglų - Department of Health (Therapeutic Goods Administration)

link medical products pty ltd t/a link pharmaceuticals - acetylcysteine -

Australija - anglų - Department of Health (Therapeutic Goods Administration)

link medical products pty ltd t/a link pharmaceuticals - candesartan cilexetil, quantity: 32 mg; hydrochlorothiazide, quantity: 25 mg - tablet, uncoated - excipient ingredients: magnesium stearate; lactose monohydrate; iron oxide red; hyprolose; carmellose calcium; iron oxide yellow; macrogol 8000; maize starch - the treatment of hypertension. treatment should not be initiated with these fixed dose combinations.

Australija - anglų - Department of Health (Therapeutic Goods Administration)

link medical products pty ltd t/a link pharmaceuticals - hydrochlorothiazide, quantity: 12.5 mg; candesartan cilexetil, quantity: 32 mg - tablet, uncoated - excipient ingredients: carmellose calcium; iron oxide yellow; lactose monohydrate; hyprolose; macrogol 8000; magnesium stearate; maize starch - the treatment of hypertension. treatment should not be initiated with these fixed dose combinations.

Australija - anglų - Department of Health (Therapeutic Goods Administration)

link medical products pty ltd t/a link pharmaceuticals - hydrochlorothiazide, quantity: 12.5 mg; candesartan cilexetil, quantity: 16 mg - tablet, uncoated - excipient ingredients: carmellose calcium; iron oxide yellow; iron oxide red; maize starch; magnesium stearate; hyprolose; lactose monohydrate; macrogol 8000 - the treatment of hypertension. treatment should not be initiated with this fixed dose combination.

Australija - anglų - Department of Health (Therapeutic Goods Administration)

link medical products pty ltd t/a link pharmaceuticals - hydralazine hydrochloride -